Skip to main content

Saturn Medic

Clinical Subject Page

Pancreatic Pseudocyst

A Pancreatic Pseudocyst is an encapsulated collection of pancreatic fluid that usually develops 4 weeks after an episode of acute pancreatitis and can also occur in chronic pancreatitis. Unlike a true cyst, it does not have an epithelial lining; its wall is made of fibrous (granulation) tissue.

ICD-10

K86.3

Specialty

Gastroenterology

Onset

Chronic

Reviewed

July 2026

On This Page

Overview

  • Forms when pancreatic duct damage causes leakage of pancreatic secretions.
  • The leaked fluid triggers inflammation and becomes surrounded by fibrous tissue, forming a pseudocyst.
  • Many patients are asymptomatic, while others develop symptoms due to pressure on nearby organs (e.g., abdominal pain, vomiting, jaundice).
  •  

Etiology & Risk Factors

Etiology

  • Acute pancreatitis (most common cause)
  • Chronic pancreatitis
  • Pancreatic duct injury or disruption, causing leakage of pancreatic secretions
  • The leaked fluid becomes surrounded by granulation (fibrous) tissue, forming a pseudocyst.

Risk Factors

  • Previous acute pancreatitis
  • Chronic pancreatitis (up to 30% of patients may develop pseudocysts)
  • Conditions that increase the risk of pancreatitis (e.g., alcohol-related chronic pancreatitis)

 

Pancreatic pseudocysts are usually a complication of acute or chronic pancreatitis caused by leakage of pancreatic fluid from damaged pancreatic ducts.

Pathophysiology

Acute/Chronic pancreatitis → Pancreatic duct damage/disruption → Leakage of pancreatic secretions → Inflammatory reaction in surrounding tissue → Encapsulation of fluid by granulation (fibrous) tissue → Formation of a pancreatic pseudocyst

Clinical Presentation

  • Often asymptomatic
  • Painless abdominal mass
  • Pressure effects on nearby organs:
    • Gastric outlet obstruction: early satiety, nonbilious vomiting, abdominal pain
    • Distal duodenal obstruction: bilious vomiting, steatorrhea
    • Bile duct obstruction: jaundice

 

Most pancreatic pseudocysts are asymptomatic. Symptoms usually occur when the pseudocyst becomes large enough to compress adjacent organs.

History Taking

Ask about:

    • Have you had a recent episode of acute pancreatitis? (especially within the last 4 weeks)
    • Do you have a history of chronic pancreatitis?
    • Do you have persistent or worsening upper abdominal pain?
    • Have you noticed a lump or fullness in your upper abdomen?
    • Do you feel full quickly (early satiety) or have nausea/vomiting?
    • Is the vomiting bilious (green) or nonbilious?
    • Have you developed jaundice (yellow eyes/skin)?
    • Have you had unexplained weight loss or loss of appetite?
    • Do you have fever or chills? (suggests infection)
    • Have you had sudden severe abdominal pain, dizziness, or fainting? (suggests rupture or hemorrhage)
    •  

Physical Examination

General examination

  • Usually normal if asymptomatic
  • Jaundice if bile duct obstruction is present
  • Fever may indicate an infected pseudocyst

Abdominal examination

  • Painless, palpable upper abdominal (epigastric) mass
  • Epigastric fullness or distention
  • Mild abdominal tenderness if symptomatic
  • Signs of gastric outlet obstruction (abdominal distention) in large pseudocysts

Signs of complications

  • Jaundice → biliary obstruction
  • Fever and abdominal pain → infected pseudocyst
  • Sudden severe abdominal pain with signs of shock → hemorrhage or rupture (medical emergency)

Investigations

Imaging (Main investigations)

  • CT abdomen with IV contrast – First-line and preferred test
    • Shows a well-defined, encapsulated extrapancreatic fluid collection
  • Abdominal ultrasound
    • Fast and readily available
    • Useful for detecting pseudocysts but may miss small lesions
  • MRI/MRCP
    • Highly sensitive and specific
    • Better delineates pancreatic duct anatomy
  • ERCP
    • More invasive; mainly used when therapeutic intervention (e.g., drainage) is planned

Laboratory tests

  • Routine blood tests are used to assess the underlying pancreatitis and complications (no laboratory test specifically confirms a pancreatic pseudocyst).

Contrast-enhanced CT is the investigation of choice for diagnosing and assessing a pancreatic pseudocyst.

Diagnosis

Diagnosis is based on :

Diagnostic Features

  • History of acute or chronic pancreatitis (typically ≥ 4 weeks after acute pancreatitis)
  • Contrast-enhanced CT abdomen (first-line)
  • Shows an extrapancreatic fluid collection
  • Well-defined wall/capsule with contrast enhancement
  • Supportive imaging (if needed)
  • Abdominal ultrasound
  • MRI/MRCP
  • ERCP (gold standard when therapeutic intervention is planned)

 

-A well-encapsulated pancreatic fluid collection seen on contrast CT ≥ 4 weeks after pancreatitis is diagnostic of a pancreatic pseudocyst.

Related Topics

Management

1. Conservative management

(for small ≤ 5 cm, asymptomatic, uncomplicated pseudocysts)

  • Observation with imaging follow-up
  • Pain control (nonopioid analgesics if possible)
  • Antiemetics if needed
  • Low-fat diet with small, frequent meals
  • Alcohol cessation

2. Endoscopic drainage (First-line intervention)

Indications:

  • Symptomatic pseudocysts (persistent pain, nausea/vomiting, anorexia, weight loss)
  • Large (> 5 cm) and persistent (> 6 weeks) pseudocysts
  • Complications:
    • Infection
    • Hemorrhage
    • Gastric outlet, duodenal, or biliary obstruction
    • Pancreatic pseudoaneurysm
    • Compression of major vessels
  • Suspected malignancy

3. Percutaneous drainage

  • Used if endoscopic drainage is not feasible or has failed

4. Surgical drainage

  • Reserved for failed endoscopic/percutaneous treatment or when surgery is needed for associated complications
  • Procedures include:
    • Cystogastrostomy
    • Cystoduodenostomy
    • Cystojejunostomy

Complications

  • Infection → fever, abdominal pain, sepsis
  • Rupture → pancreatic ascites, pancreaticopleural fistula
  • Hemorrhage (erosion into adjacent blood vessels) → sudden severe abdominal pain, hemorrhagic shock
  • Gastric outlet obstruction → early satiety, nausea, nonbilious vomiting
  • Duodenal obstruction → bilious vomiting, steatorrhea
  • Biliary obstruction → obstructive jaundice
  • Pancreatic pseudoaneurysm
  • Compression of major blood vessels
  • Pancreaticopleural fistula

Prognosis

  • Good prognosis in most patients with small (≤ 5 cm), asymptomatic pseudocysts, as many resolve spontaneously with conservative management.
  • Large (> 5 cm), persistent (> 6 weeks), symptomatic, or complicated pseudocysts are unlikely to resolve without intervention and usually require drainage.
  • Endoscopic drainage has a high success rate and is the preferred treatment when intervention is needed.
  • Prognosis worsens if complications develop, such as infection, hemorrhage, or rupture, which require urgent management.

Key Points / Clinical Pearls

  • Occurs ≥ 4 weeks after pancreatitis.
  • No epithelial lining (fibrous wall only).
  • Best test: Contrast-enhanced CT abdomen.
  • Small (≤ 5 cm), asymptomatic → observe.
  • Large (> 5 cm), persistent (> 6 weeks), symptomatic, or complicated → endoscopic drainage.
  • Major complications: Infection, hemorrhage, rupture, and obstruction.
  • National Center for Biotechnology Information (NIH). Pancreatic Pseudocyst, StatPearls.
  • Banks PA, Bollen TL, Dervenis C, et al; Acute Pancreatitis Classification Working Group. Classification of Acute Pancreatitis - 2012: Revision of the Atlanta Classification and Definitions by International Consensus. Gut. 2013;62:102-111.
  • Pancreatic Pseudocyst: The Past, the Present, and the Future. World J Gastroenterol. PMC11287700.
  • Systematic Review Comparing Endoscopic, Percutaneous and Surgical Pancreatic Pseudocyst Drainage. World J Gastroenterol. PMC4804189.
  • MedlinePlus, National Library of Medicine (NIH). Pancreatic Pseudocyst: Medical Encyclopedia.